Pacira BioSciences (PCRX) Earnings Date & Reports

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

PCRX is expected to report earnings to rise 8.43% to 65 cents per share on August 04

Pacira BioSciences PCRX Stock Earnings Reports

Q2'26

Est.

$0.65

Q1'26

Beat

by $0.04

Q4'25

Missed

by $0.33

Q3'25

Beat

by $0.05

Q2'25

Beat

by $0.02

The last earnings report on April 30 showed earnings per share of 60 cents, beating the estimate of 56 cents. With 47.38K shares outstanding, the current market capitalization sits at 899.49M.

View a ticker or compare two or three

Compare

PCRX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for PCRX